Yawen Zhang

Shanghai Key Laboratory Of Diabetes Mellitus, Shanghai Key Clinical Centre For Metabolic Disease
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Sex-Specific Associations of Inflammatory Biomarkers With All-Cause and Cardiovascular Mortality Across Glycaemic Status: A Prospective UK Biobank Study.

Sex-Specific Associations of Inflammatory Biomarkers With All-Cause and Cardiovascular Mortality Across Glycaemic Status: A Prospective UK Biobank Study.

Journal: Diabetes, obesity & metabolism

Published: January 10, 2026

Long-term impact of newly-proposed clinical obesity on autoimmune disease incidence: insights from the UK Biobank.

Long-term impact of newly-proposed clinical obesity on autoimmune disease incidence: insights from the UK Biobank.

Journal: International journal of obesity (2005)

Published: May 23, 2025

Contributions of Clinical Obesity and Preclinical Obesity to the All-Cause Mortality Risk: Findings From the UK Biobank Cohort.

Contributions of Clinical Obesity and Preclinical Obesity to the All-Cause Mortality Risk: Findings From the UK Biobank Cohort.

Journal: Diabetes/metabolism research and reviews

Published: May 23, 2025

Handgrip Strength and Trajectories of Preclinical Obesity Progression: A Multistate Model Analysis Using the UK Biobank.

Handgrip Strength and Trajectories of Preclinical Obesity Progression: A Multistate Model Analysis Using the UK Biobank.

Journal: The Journal of clinical endocrinology and metabolism

Published: May 19, 2025

Dynamic phenotypes of preclinical and clinical obesity in relation to new-onset cancer risk: A longitudinal analysis from the UK biobank.

Dynamic phenotypes of preclinical and clinical obesity in relation to new-onset cancer risk: A longitudinal analysis from the UK biobank.

Journal: Diabetes, obesity & metabolism

Published: May 02, 2025

Efficacy and safety of fruquintinib as third- or further-line therapy for patients with advanced bone and soft tissue sarcoma: a multicenter retrospective study.

Efficacy and safety of fruquintinib as third- or further-line therapy for patients with advanced bone and soft tissue sarcoma: a multicenter retrospective study.

Journal: Anti-cancer drugs

Published: December 20, 2022

Dihydroartemisinin Potentiates VEGFR-TKIs Antitumorigenic Effect on Osteosarcoma by Regulating Loxl2/VEGFA Expression and Lipid Metabolism Pathway.

Dihydroartemisinin Potentiates VEGFR-TKIs Antitumorigenic Effect on Osteosarcoma by Regulating Loxl2/VEGFA Expression and Lipid Metabolism Pathway.

Journal: Journal of Cancer

Published: December 07, 2022

The long non-coding RNA CRNDE promotes osteosarcoma proliferation and migration by sponging miR-136-5p/MRP9 axis.

The long non-coding RNA CRNDE promotes osteosarcoma proliferation and migration by sponging miR-136-5p/MRP9 axis.

Journal: Annals of translational medicine

Published: May 20, 2022

Ailanthone Inhibits Proliferation, Migration and Invasion of Osteosarcoma Cells by Downregulating the Serine Biosynthetic Pathway.

Ailanthone Inhibits Proliferation, Migration and Invasion of Osteosarcoma Cells by Downregulating the Serine Biosynthetic Pathway.

Journal: Frontiers in oncology

Published: December 23, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026